drugset / Trial / NCT02688062
NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI
Phase 1/2
Unknown
22 enrolled
Chinese Academy of Sciences
First Hospitals affiliated to the China PLA General Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) on neurological recovery following chronic and complete spinal cord injury, compared to the treatment of surgical intradural decompression and adhesiolysis only.
Timeline
- Start
- 2016-01
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bone marrow mononuclear cells | Cell therapy | — | — |